If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
CHICAGO, May 29 (HSMN NewsFeed) — Spirus Clinical, Inc. (www.spirusmed.com), a major developer of diagnostic and therapeutic advancement systems for gastroenterology, urology and gynecology, announced that physicians using its Endo-Ease(TM) line of dev…
Devices, Gastroenterology
Spirus Clinical, Endo-Ease, pan-endoscopy, Discovery SB
Posts from ‘May, 2009’
Spirus Pharmaceutical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
INDIANAPOLIS, May 29 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) announced today that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of ALIMTA® (pemetre…
Biopharmaceuticasl, Oncology, Regulatory
Eli Lilly, ALIMTA, pemetrexed, NSCLC
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
* CHMP recommends lifting of treatment restrictions for Neupro® in Europe * Recommends allowing Neupro® to be available to all patients with Parkinson’s disease * Recommends allowing Neupro® to be launched for the treatment of moderate to…
Biopharmaceuticals, Neurology, Regulatory
UCB, Neupro, rotigotine transdermal patch, Parkinson’s disease
Bausch and Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (’Pink Eye’)
Besivance Adds to Bausch & Lomb’s Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) MADISON, N.J., May 29 (HSMN NewsFeed) — Bausch & Lomb, a world leader in eye health, toda…
Biopharmaceuticals, Ophthalmology, FDA
Bausch & Lomb, Besivance, besifloxacin, pink eye, conjunctivitis
FDA Approves SBi’s S.T.A.R. Total Ankle Replacement System
FDA-approved Instructions for Use indicate S.T.A.R.® is superior in efficacy and comparable in safety to ankle fusion in clinical trials Only FDA-approved, three-piece, mobile-bearing total ankle replacement Only FDA-approved total ankle replacem…
Devices, Orthopaedic, FDA
Small Bone Innovations, Scandinavian Total Ankle
500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
BERLIN, May 28 (HSMN NewsFeed) — The 500th patient was supported with the Berlin Heart EXCOR® Pediatric Ventricular Assist Device (also known as the "Berlin Heart") since the first implantation of the device in 1990. The patient, an 11-mon…
Devices, Cardiology
Berlin Heart, ventricular assist device, Berlin Heart EXCOR
Power3 Clinical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer’s
Prospective Trials in the U.S. Confirm Earlier Retrospective Studies Initiated by the Company HOUSTON, TX–May 28, 2009 — Power3 Laboratory Products, Inc. (OTC BB:PWRM.OB ) announced today a significant breakthrough related to the diagnosis of patients wi…
Diagnostics, Neurology
Power3 Medical Products, NuroPro, Alzheimer’s disease
Astellas Announces New Vice President of Marketing
DEERFIELD, Ill., May 28 (HSMN NewsFeed) — Astellas Pharma US, Inc. ("Astellas") recently hired Walt Johnston as vice president of marketing. Reporting directly to Patrick Shea, senior vice president of product management & sales, Johnston will be respo…
Biopharmaceuticals, Personnel
Astellas Pharma
Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
NATICK, Mass., May 27 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) today announced that Ursula Burns and Kristina Johnson have resigned from the Company’s Board of Directors after accepting senior appointments in industry and government,…
Devices, Personnel
Boston Scientific
Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
SAN DIEGO, May 27 (HSMN NewsFeed) — Accumetrics, Inc. announces today it has signed new exclusive distribution agreements for its VerifyNow(R) System in several European countries. Distribution of Accumetrics’ VerifyNow products will be handled by AAZ i…
Diagnostics, Cardiology, Distribution
Accumetrics, VerifyNow, GP IIb/IIIa, antiplatelet
